DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Prothena Corporation (NASDAQ: PRTA)

21.55 1.17 (5.74%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PRTA $21.55 5.74%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $20.34
Previous Close $20.38
Daily Range $20.00 - $21.82
52-Week Range $16.71 - $49.24
Market Cap $590.1M
P/E Ratio 11.78
Dividend (Yield) $0.00 (0.0%)
Volume 650,933
Average Daily Volume 286,072
Current FY EPS -$0.44

Sector

Industry

Prothena Corporation (PRTA) Description

Prothena Corporation plc - Ordinary Shares Website: http://www.prothena.com/

News & Commentary Rss Feed

The Next Biotech Buyout Stock

Three Fool healthcare analysts weigh in on three potential biotechnology takeover targets.

Health Care Sector Update for 12/16/2014: PRTA,NVGN,CYCC

UPDATE: Prothena Receives FDA Fast Track Designation for NEOD001

Commit To Purchase Prothena Corp At $17.50, Earn 33.1% Annualized Using Options

Prothena Corporation (PRTA) Falls: Stock Goes Down 5% - Tale of the Tape

Prothena Initiates NEOD001 Global Phase 3 Registrational Trial Based On Positive Results In Ongoing

Prothena Initiates NEOD001 Global Phase 3 Registrational Trial Based On Positive Results In Ongoing Phase 1/2 Study of NEOD001 In Patients With AL Amyloidosis

Prothena Reports Initiation of NEOD001 Global Phase 3 Registrational Trial Based on Positive Results

Prothena Reports Initiation of NEOD001 Global Phase 3 Registrational Trial Based on Positive Results in Ongoing Phase 1/2 Study

Why You Shouldn't Bet Against Prothena Corporation (PRTA) Stock - Tale of the Tape

Prothena's Management Presents at 2014 Credit Suisse Healthcare Conference (Transcript)

Why Prothena Corporation (PRTA) Stock Might be a Great Pick - Tale of the Tape

See More PRTA News...